Product Information
CARVEDILOL 3.125 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0170 per EA under NDC 65862014205. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
3.125 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862014205
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARVEDILOLApproval Type
Generic (ANDA)
FDA Application
ANDA078332On Market Since
9/5/2007
Pharmacological Classes
Price Statistics
The NADAC for CARVEDILOL 3.125 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 52.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0170 per EA |
|---|---|
| All-time high | $0.0370 (Mar 12, 2014) |
| All-time low | $0.0133 (Nov 20, 2024) |
| 52-week high | $0.0174 |
| 52-week low | $0.0163 |
| Median price | $0.0232 |
| Average price | $0.0240 |
| Largest weekly change | -22.2% (Nov 20, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARVEDILOL 3.125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 3.125 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0170 per EA (NDC 65862014205), effective Jun 24, 2026.
How has the price of CARVEDILOL 3.125 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARVEDILOL 3.125 MG TABLET has declined 52.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARVEDILOL 3.125 MG TABLET?
Since Nov 28, 2013, the NADAC for CARVEDILOL 3.125 MG TABLET has ranged from a low of $0.0133 (Nov 20, 2024) to a high of $0.0370 (Mar 12, 2014), with a median of $0.0232 per EA.
Are there cheaper alternatives to CARVEDILOL 3.125 MG TABLET?
9 NADAC-published products share the same active ingredient, strength, and dosage form as CARVEDILOL 3.125 MG TABLET, but none are currently priced below it.
Who manufactures CARVEDILOL 3.125 MG TABLET?
CARVEDILOL 3.125 MG TABLET (NDC 65862014205) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification